Mark Stolper - 15 Aug 2022 Form 4 Insider Report for SURGALIGN HOLDINGS, INC.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 15 Aug 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Aug 2022, 12:42:00 UTC
Prior SEC filing: 11 Feb 2022
Next SEC filing: 05 Jan 2023
Source filing: View source filing
Reporting owner signature: By Jessica Rumschlag as attorney in fact

Key filing fact

Mark Stolper filed Form 4 for SURGALIGN HOLDINGS, INC. on 17 Aug 2022.

Key facts

This page summarizes Mark Stolper's Form 4 filing for SURGALIGN HOLDINGS, INC..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2022, 12:42.

Change

Previous filing in this sequence was filed on 11 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRGA transaction

Common Stock

Award

Transaction value: $0
Shares: +22,857
Change %: +380%
Price: $0.000000
Shares after: 28,867
Date: 15 Aug 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of restricted stock of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant.

Footnote F2

The total shares reported reflect 1:30 reverse stock split on May 17, 2022.